What is a key intervention in managing respiratory distress in patients with known COPD?

The management of respiratory distress in patients with known Chronic Obstructive Pulmonary Disease (COPD) often involves the use of corticosteroids such as Solumedrol (methylprednisolone). This medication helps to reduce inflammation in the airways, facilitating better airflow and improving the patient's overall respiratory function. In acute situations, addressing the inflammatory response can significantly relieve distress and prevent further complications.

In the context of COPD, patients often experience exacerbations due to inflammation and bronchospasm, and systemic corticosteroids can help mitigate these effects. While bronchodilators are commonly used and are vital in managing COPD, the question specifically emphasizes a key intervention, which ties closely to inflammation management.

Therefore, while other options may have roles in respiratory management, the administration of Solumedrol stands out as a critical intervention for addressing the underlying inflammation characteristic of COPD exacerbations.